{"text": ["Teva", "Shares", "Fall", "as", "FDA", "OKs", "Another", "Generic", "Version", "of", "Multiple", "Sclerosis", "Drug"], "created_at": "2018-02-13 22:33:00"}
{"text": ["Postponed", "Common", "Share", "Consolidation", "and", "Name", "Change"], "created_at": "2018-02-13 22:25:00"}
{"text": ["IIROC", "Trading", "Halt", "-", "NVS"], "created_at": "2018-02-13 16:24:00"}
{"text": ["Analyzing", "Pfizer\u2019s", "Ibrance", "and", "Xalkori", "after", "2Q17"], "created_at": "2018-02-13 15:32:20"}
{"text": ["Intercept", "Starts", "OCA", "Trial", "for", "NASH", "Patients", "With", "Cirrhosis"], "created_at": "2018-02-13 15:11:44"}
{"text": ["Intercept", "Starts", "OCA", "Trial", "for", "NASH", "Patients", "With", "Cirrhosis"], "created_at": "2018-02-13 15:11:44"}
{"text": ["Novartis", "gains", "U.S.", "approval", "for", "delayed", "MS", "drug"], "created_at": "2018-02-13 14:53:45"}
{"text": ["Teva", "shares", "drop", "3%", "after", "rival", "generic", "product", "approved", "and", "launched"], "created_at": "2018-02-13 14:09:51"}
{"text": ["Pfizer\u2019s", "Sutent", "Generated", "Higher", "Revenues", "in", "4Q17"], "created_at": "2018-02-13 14:03:16"}
{"text": ["Novartis", "gains", "U.S.", "approval", "for", "delayed", "MS", "drug"], "created_at": "2018-02-13 13:56:32"}
{"text": ["The", "Swiss", "Stock", "Market", "Pulled", "Back", "On", "Inflation", "Concerns"], "created_at": "2018-02-13 12:19:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Pulled", "Back", "On", "Inflation", "Concerns"], "created_at": "2018-02-13 12:19:00"}
{"text": ["Sandoz", "Announces", "FDA", "Approval", "Of", "Glatopa", "-", "Quick", "Facts"], "created_at": "2018-02-13 01:36:00"}
{"text": ["Sandoz", "Announces", "FDA", "Approval", "Of", "Glatopa", "-", "Quick", "Facts"], "created_at": "2018-02-13 01:36:00"}
